arginine has been researched along with Ventricular Fibrillation in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (71.43) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aspelin, T; Björkman, JA; Eriksen, M; Ilebekk, A; Lyberg, T; Nordlander, M; Sevre, K | 1 |
Brack, KE; Coote, JH; Ng, GA; Patel, VH | 1 |
Grötsch, H; Hropot, M; Klaus, E; Langer, KH; Linz, W; Schölkens, BA; Wiemer, G | 1 |
Curtis, MJ; Pabla, R | 2 |
Papp, JG; Parratt, JR; Szekeres, L; Vegh, A | 1 |
Abacioğlu, N; Altuğ, S; Cakici, I; Demiryürek, AT; Kanzik, I; Uzun, O | 1 |
7 other study(ies) available for arginine and Ventricular Fibrillation
Article | Year |
---|---|
Ventricular fibrillation induced by ischemia-reperfusion is not prevented by the NPY Y2 receptor antagonist BIIE0246.
Topics: Animals; Arginine; Benzazepines; Biomarkers; Blood Pressure; Body Temperature; Carbon Dioxide; Cardiac Output; Coronary Circulation; Coronary Stenosis; Disease Models, Animal; Female; Heart Rate; Hematocrit; Male; Myocardial Reperfusion; Myocardial Reperfusion Injury; Oxygen; Potassium; Receptors, Neuropeptide Y; Swine; Tachycardia, Ventricular; Ventricular Fibrillation | 2006 |
Nitric oxide mediates the vagal protective effect on ventricular fibrillation via effects on action potential duration restitution in the rabbit heart.
Topics: Action Potentials; Animals; Arginine; Autonomic Nervous System; Cardiac Pacing, Artificial; Disease Models, Animal; Electric Stimulation; Enzyme Inhibitors; Heart; Heart Rate; Heart Ventricles; In Vitro Techniques; Male; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Perfusion; Rabbits; Time Factors; Vagus Nerve; Ventricular Fibrillation; Ventricular Function | 2007 |
Ramipril prevents the detrimental sequels of chronic NO synthase inhibition in rats: hypertension, cardiac hypertrophy and renal insufficiency.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Blood Pressure; Cardiomegaly; Cyclic GMP; Hypertension; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Ramipril; Rats; Rats, Wistar; Renal Insufficiency; Ventricular Fibrillation | 1994 |
Effects of NO modulation on cardiac arrhythmias in the rat isolated heart.
Topics: Animals; Arginine; Arrhythmias, Cardiac; Coronary Circulation; Heart Rate; In Vitro Techniques; Male; Models, Cardiovascular; Myocardial Ischemia; Myocardial Reperfusion; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Rats; Rats, Wistar; Time Factors; Ventricular Fibrillation | 1995 |
Prevention by an inhibitor of the L-arginine-nitric oxide pathway of the antiarrhythmic effects of bradykinin in anaesthetized dogs.
Topics: Anesthesia; Animals; Anti-Arrhythmia Agents; Arginine; Blood Pressure; Bradykinin; Cardiac Complexes, Premature; Coronary Vessels; Dogs; Hemodynamics; NG-Nitroarginine Methyl Ester; Nitric Oxide; Tachycardia, Supraventricular; Ventricular Fibrillation | 1993 |
Endogenous protection against reperfusion-induced ventricular fibrillation: role of neuronal versus non-neuronal sources of nitric oxide and species dependence in the rat versus rabbit isolated heart.
Topics: Animals; Arginine; Blood Flow Velocity; Enzyme Inhibitors; Heart Rate; In Vitro Techniques; Indazoles; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Neurons; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rabbits; Rats; Rats, Wistar; Species Specificity; Ventricular Fibrillation | 1996 |
The role of nitric oxide in digoxin-induced arrhythmias in guinea-pigs.
Topics: Animals; Arginine; Arrhythmias, Cardiac; Blood Pressure; Digoxin; Guinea Pigs; In Vitro Techniques; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Time Factors; Ventricular Fibrillation | 1999 |